B. Milleron

Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)

Fabrice Barlési, Julien Mazières, Jean‐Philippe Merlio et al. · The Lancet · 2016 · 969 citations · Full text

Advanced Lung Disease, Medicine, Pathology +8

Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial

Gérard Zalcman, Julien Mazières, J. Margery et al. · The Lancet · 2015 · 965 citations

Medicine, Pathology, Pleural Disease +5

Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial

Élisabeth Quoix, Gérard Zalcman, Jean-Philippe Oster et al. · The Lancet · 2011 · 573 citations

Elderly Patients, Medicine, Metronomic Therapy +7

Preoperative Chemotherapy Followed by Surgery Compared With Primary Surgery in Resectable Stage I (Except T1N0), II, and IIIa Non–Small-Cell Lung Cancer

A Depierre, B. Milleron, Denis Moro‐Sibilot et al. · Journal of Clinical Oncology · 2002 · 569 citations

Evaluation of microscopic tumor extension in non–small-cell lung cancer for three-dimensional conformal radiotherapy planning

P. Giraud, Martine Antoine, Anne Larrouy et al. · International Journal of Radiation Oncology*Biology*Physics · 2000 · 435 citations

Non–small-cell Lung Cancer, Radiation Therapy, Medical Imaging +8